AFArianne M Foster

Arianne M Foster

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Arianne M Foster has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Andrés Buonanno

    Section of Molecular Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States of America

    1 shared publication
  • Grazia M S Mancini

    Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands

    1 shared publication
  • Herman Douglas Morris

    Department of Radiology and Bioengineering Uniformed Services University Bethesda Maryland USA

    1 shared publication
  • Jeffrey Mercurio

    Cell Biology and Neurobiology Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States of America

    1 shared publication
  • Juan S. Bonifacino

    Division of Neuroscience and Cellular Structure, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA

    1 shared publication
  • Loreto Cuitino

    Laboratory of Ocular and Systemic Autoimmune Diseases, Faculty of Medicine, University of Chile, Santiago, Chile

    1 shared publication

Latest Publications

  • Open Access

    Altered distribution of ATG9A and accumulation of axonal aggregates in neurons from a mouse model of AP-4 deficiency syndrome

    by Raffaella De Pace, Miguel Skirzewski, Markus Damme, Rafael Mattera, Jeffrey Mercurio, Arianne M Foster, Loreto Cuitino, Michal Jarnik, Victoria Hoffmann, H Douglas Morris, et al.

    The hereditary spastic paraplegias (HSP) are a clinically and genetically heterogeneous group of disorders characterized by progressive lower limb spasticity. Mutations in subunits of the heterotetrameric (ε-β4-μ4-σ4) adaptor protein 4 (AP-4) complex cause an autosomal recessive form of complicated HSP referred to as “AP-4 deficiency syndrome”. In addition to lower limb spasticity, this syndrome features intellectual disability, microcephaly, seizures, thin corpus callosum and upper limb spasticity. The pathogenetic mechanism, however, remains poorly understood. Here we report the characterization of a knockout (KO) mouse for the AP4E1 gene encoding the ε subunit of AP-4. We find that AP-4 ε KO mice exhibit a range of neurological phenotypes, including hindlimb clasping, decreased motor coordination and weak grip strength. In addition, AP-4 ε KO mice display a thin corpus callosum and axonal swellings in various areas of the brain and spinal cord. Immunohistochemical analyses show that the transmembrane autophagy-related protein 9A (ATG9A) is more concentrated in the trans-Golgi network (TGN) and depleted from the peripheral cytoplasm both in skin fibroblasts from patients with mutations in the μ4 subunit of AP-4 and in various neuronal types in AP-4 ε KO mice. ATG9A mislocalization is associated with increased tendency to accumulate mutant huntingtin (HTT) aggregates in the axons of AP-4 ε KO neurons. These findings indicate that the AP-4 ε KO mouse is a suitable animal model for AP-4 deficiency syndrome, and that defective mobilization of ATG9A from the TGN and impaired autophagic degradation of protein aggregates might contribute to neuroaxonal dystrophy in this disorder. Hereditary spastic paraplegia (HSP) is a genetic disorder characterized by progressive stiffness of the legs. To date, mutations in more than 70 genes have been shown to cause HSP. Four of these genes encode the subunits of adaptor protein 4 (AP-4), a heterotetrameric complex involved in intracellular protein trafficking. AP-4 deficiency belongs to a subset of complicated HSPs featuring intellectual disability, seizures, microcephaly and thinning of the corpus callosum in addition to leg stiffness. Here we describe the characteristics of mice lacking the expression of the ε subunit of AP-4. These mice exhibit motor deficits consistent with those seen in the human patients. In addition, they have an abnormally thin corpus callosum and defective axons in various parts of the brain and the spinal cord. Importantly, fibroblasts from AP-4 deficient patients as well as neurons from AP-4 deficient mice fail to deliver the autophagy-related protein 9A (ATG9A) from the Golgi complex to the cell periphery. This defect is associated with accumulation of abnormal protein aggregates in axons from AP-4-deficient neurons. We conclude that AP-4 mutant mice are a suitable animal model for studies of AP-4 deficiency in humans, and that altered localization of ATG9A and aggregate formation in neurons likely contribute to the development of the disease.